NXTC
NextCureยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NXTC Profile
Nextcure, Inc.
A clinical-stage biopharmaceutical company that developing immunomedicines to treat cancer and other immune-related diseases
9000 Virginia Manor Road, Suite 200, Beltsville, Maryland 20705
--
NextCure, Inc., incorporated in Delaware in September 2015, is headquartered in Beltsville, Maryland. The company is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel first-in-class immune drugs to treat cancer and other immune-related diseases by restoring normal immune function. Through its proprietary functional, integrated, NextCure Discovery (" FIND-IO ") platform in immuno-oncology, the Company studies a variety of immune cells to discover and understand the targets and structural components of immune cells and their functional effects to develop immunohistochemistry.
